吸烟对黑色素瘤发病率的影响:通过元分析进行系统性审查
Erica B Friedman1, Gabrielle J Williams2,3, Serigne N Lo2,3
1Department of Surgery, NYU Langone Health, New York, NY, USA.
Journal of the National Cancer Institute
|June 24, 2024
概括
这项研究发现,目前的吸烟者患黑色素瘤的风险明显降低. 吸烟男性的风险降低了40%,女性的风险降低了21%.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 吸烟是众所周知的许多癌症的风险因素.
- 一个矛盾的观察是,在吸烟者中,黑色素瘤的发病率较低.
- 这一元分析研究了吸烟与黑色素瘤风险之间的关联.
研究的目的:
- 系统地分析现有的关于吸烟者与非吸烟者的黑色素瘤发病率研究.
- 量化与目前和以前的吸烟状况相关的黑色素瘤风险.
主要方法:
- 对MEDLINE和Embase数据库进行了全面的文献搜索.
- 包括的研究报告了吸烟者和从未吸烟者的黑色素瘤发病率数据.
- 使用固定效应模型进行了聚合分析,以确定风险比率 (RR).
主要成果:
- 对49项涉及59429名黑色素瘤患者的研究进行分析,发现了重要的发现.
- 目前男性吸烟者患黑色素瘤的风险降低了40% (RR=0.60).
- 目前吸烟的女性患黑色素瘤的风险降低了21% (RR=0.79).
- 男性前吸烟者显示风险降低 (RR=0.84),但女性前吸烟者没有.
结论:
- 目前的吸烟与男性和女性黑色素瘤风险的统计显著降低有关.
- 这些发现强调了吸烟和黑色素瘤之间的复杂关系,需要进一步调查.
- 关于戒烟的公共卫生信息应该考虑这些细微的发现.
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Statistical Methods for Analyzing Epidemiological Data
349
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
349
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


